期刊文献+

多发性骨髓瘤恶性相关基因MYEOV2对NIH/3T3细胞生长的影响 被引量:1

The Effect of Multiple Myeloma Tumor-associated Gene MYEOV2 on NIH/3T3 Cells Growth
原文传递
导出
摘要 目的 分析多发性骨髓瘤恶性相关基因MYEOV2对NIH/ 3T3细胞生长的影响。方法 将MYEOV2基因克隆到真核表达载体pcDNA3 1( +)上 ,并将阳性重组子通过脂质体转染入NIH/ 3T3细胞中 ,G418筛选获得转染阳性克隆并用RT -PCR检测MYEOV2基因的表达。运用流式细胞分类法、细胞生长曲线分析MYEOV2基因对NIH/ 3T3细胞生长的影响。结果 成功获得转染pcDNA3 1( +) /MYEOV2的细胞阳性克隆。流式细胞分析显示转染pcDNA3 1( +) /MYEOV2、转染空载体及未转染的NIH/ 3T3细胞的S期细胞分别为 3 0 9%、2 0 1%、16 1% ,前者较后两者S期细胞增多 ,有显著性差异 (P <0 0 5 )。细胞生长曲线显示转染pcDNA3 1( +) /MYEOV2、转染空载体、未转染的NIH/ 3T3细胞的倍增时间分别为 13 6h、2 5 3h、2 7 4h ,前者细胞倍增时间较后两者缩短 ,有显著性差异 (P <0 0 5 )。结论 MYEOV2基因的表达增加促进DNA合成增加 ,细胞增殖加快 。 Objective To analyze the influence of multiple myeloma tumor-associated gene MYEOV2 on NIH/3T3 cells growth. Methods The recombinant plasmid, pcDNA3.1(+)/MYEOV2, was constructed and subsequently transfected into NIH/3T3 cells by liposome. The positive clones of the transfected NIH/3T3 cells were obtained by G418 selection. RT-PCR was used to detecte the expression of MYEOV2 gene in the cells. Fluorescence-activated cell sorting (FACS) and cell grow curve drawing were applied to analyze the influence of MYEOV2 gene on NIH/3T3 cells proliferation. Results The cell clones stably expressing MYEOV2 gene were obtained. FACS analysis showed that the percentage of S phase cell of pcDNA3.1(+)/MYEOV2-transfected cells, pcDNA3.1(+) -transfected cells and non-transfected cells was 30.9%, 20.1% and 16.1%, respectively, and the difference of sphase cell percentage between pcDNA3.1(+)/MYEOV2-transfected cells and the other two groups of cells was significant (P<0.05). The population double time(PDT) of pcDNA3.1(+)/MYEOV2-transfected cells, pcDNA3.1(+)-transfected cells, and non-transfected cells was 13.6, 25.3 and 27.4 hours, respectively, the difference of which between pcDNA3.1(+)/MYEOV2-transfected cells and the other two groups of cells was also significant(P<0.05). Conclusion The expression of MYEOV2 in NIH/3T3 cells had the potential to stimulate DNA synthesis and lead to cell proliferate rapidly. These results suggested that MYEOV2 gene might be involved in the proliferation of multiple myeloma cells.
出处 《中国医师杂志》 CAS 2004年第8期1009-1011,共3页 Journal of Chinese Physician
基金 国家自然科学基金资助项目 (NO 39880 0 2 1 NO 30 2 70 576) 湖南省杰出青年科学基金资助项目 (NO 0 4JJ1 0 0 6)
关键词 多发性骨髓瘤 恶性基因 MYEOV2 NIH/3T3 细胞生长 细胞周期 肿瘤 Multiple myeloma MYEOV2 Cell cycle
  • 相关文献

参考文献5

  • 1Pope B, Brown R, Luo XF, et al. Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumor suppressor genes and can be monitored by the oncoprotein phenotype[J].Leuk lymph
  • 2Ozaki S, Kosaka M. Multiple myeloma: new aspects of biology and treatment[J]. J Med Invest,1998,44(3-4):127-136
  • 3Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA[J]. Proc Natl Acad Sci USA, 1997,94(3): 952-955
  • 4Waga S, Stillman B. The DNA replication fork in eukaryotic cells[J]. Annu Rev Biochem,1998,67:721-751
  • 5汤立军,胡维新,何莉芳,田菁燕,刘新发,谭达人.多发性骨髓瘤细胞中一个表达上调基因的克隆与分析[J].中国生物化学与分子生物学报,2003,19(1):60-63. 被引量:1

二级参考文献7

  • 1[1]Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA,1997,94(3):952~955
  • 2[3]Sambrook J,Russell D W.Malecular Cloning:A Laboratory Manual, 3rd ed.New York:Cold Spring Harbor Laboratory Press.2001:11.38~11.65;2.90~2.95
  • 3[4]Alderson M R,Pike B L. Recombinant human IL-6(B cell stimulatory factor 2) enhances immunoglobulin secretion by single murine hapten-specific B cells in the absence of cell division. Int Immunol, 1989, 1(1):20~28
  • 4[5]Gado K, Domjan G,Hegyesi H,Falus A. Role of interleukin-6 in the pathogenesis of multiple myeloma. Cell Biol Int, 2000,24(4):195~209
  • 5[6]Jelinek D F. Mechanisms of myeloma cell growth control. Hematol Oncol Clin North Am,1999,13(6):1145~1157
  • 6[7]Ozaki S,Kosaka M. Multiple myeloma: new aspects of biology and treatment. J Med Invest, 1998,44(3~4):127~136
  • 7[8]Pope B,Brown R,Luo X F, Gibson J,Joshua D. Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumor suppressor genes and can be monitored by the oncoprotein phenotype. Leuk lymphoma, 1997, 25(5,6):545~554

同被引文献6

  • 1Sekiguchi Y, Shimada A, Iehikawa K, et al. Epstein-Barr viruspositive multiple myeloma developing after immunosuppressant therapy for rheumatoid arthritis : a case report and review of literature [J]. Int J Clin Exp Pathol,2015,8(2) :2090-2102.
  • 2Sehtitz N, Marker-Hermann E. Rheumatoid arthritis and muhiple myeloma as comorbidity. Is tocilizumab a therapy option? [ J ]. Z Rheumatol,2012,71 ( 1 ) : 78-82. DOI: 10. 1007/s00393-011- 0931-2.
  • 3Shen K, Xu G, Wu Q, et al. Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies [J]. PLoS One, 2014,9 (3) : e91461. DOI: 10. 1371/joumal. pone. 0091461.
  • 4Alpay N, Artim-Esen B, Kamali S, et al. Amyloid arthropathy mimicking seronegative rheumatoid arthritis in multiple myeloma: case reports and review of the literature [ J]. Amyloid,2009,16 (4) :226-231. DOI: 10. 3109/13506120903421785.
  • 5Matsuyama Y, Nagashima T, Honne K, et al. Successful treatment of a patient with rheumatoid arthritis and IgA-K multiple myeloma with toeilizumab [J]. Intern Med,2011,50 (6) :639-642. DOI : 10. 2169/internalmedicine. 50. 4636.
  • 6安阳,马武开,钟琴,罗窅,周静.类风湿关节炎并发多发性骨髓瘤1例[J].中国民族民间医药,2012,21(16):104-104. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部